These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 34616394)

  • 1. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
    Xu X; Prens E; Florencia E; Leenen P; Boon L; Asmawidjaja P; Mus AM; Lubberts E
    Front Immunol; 2021; 12():719562. PubMed ID: 34616394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A and TNF-α-induced Dectin-1 expression may promote keratinocyte proliferation in psoriatic lesions.
    Cui W; Liu J; Kong S; Huang H; Liu L; Cao Y; Gu Z
    Eur J Dermatol; 2024 Apr; 34(2):119-130. PubMed ID: 38907541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
    Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
    Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
    Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
    Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
    Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang H; Ren C; Liu Q; Wang Q; Wang D
    Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.
    Res PC; Piskin G; de Boer OJ; van der Loos CM; Teeling P; Bos JD; Teunissen MB
    PLoS One; 2010 Nov; 5(11):e14108. PubMed ID: 21124836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells.
    Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE
    Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes.
    Ehst B; Wang Z; Leitenberger J; McClanahan D; De La Torre R; Sawka E; Ortega-Loayza AG; Strunck J; Greiling T; Simpson E; Liu Y
    Cytokine; 2021 Feb; 138():155357. PubMed ID: 33153894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of IL-33 in the epidermis: The mechanism of induction by IL-17.
    Meephansan J; Komine M; Tsuda H; Karakawa M; Tominaga S; Ohtsuki M
    J Dermatol Sci; 2013 Aug; 71(2):107-14. PubMed ID: 23764374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17A and Keratinocytes in Psoriasis.
    Furue M; Furue K; Tsuji G; Nakahara T
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ.
    Tu J; Yin Z; Guo J; He F; Long F; Yin Z
    Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.